Tony Mok's most recent trade in HUTCHMED (China) Limited - ADR was a trade of 9,690 shares done . Disclosure was reported to the exchange on Oct. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HUTCHMED (China) Ltd (ADR) | Shu Kam Tony Mok | Non-Executive Director,Senior Independent Director | 20 Oct 2025 | 9,690 | 156,085 (0%) | 0% | 0 | - | ||
| Astrazeneca plc | Tony Mok | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 126.80 per share. | 19 Nov 2024 | 1,500 | 3,500 (0%) | 0% | 126.8 | 190,195 | Ords 0.25p |
| HUTCHMED (China) Ltd (ADR) | Shu Kam Tony Mok | Non-Executive Director | 20 Oct 2024 | 9,690 | 146,395 (0%) | 0% | 0 | Ords 0.10p |